Amedica Analysis

Amedica is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Amedica delisted stock analysis is to determine its intrinsic value, which is an estimate of what Amedica is worth, separate from its market price. There are two main types of Amedica's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Amedica's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Amedica's stock to identify patterns and trends that may indicate its future price movements.
The Amedica stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Amedica is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Amedica Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Amedica's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.

Amedica Stock Analysis Notes

The company has price-to-book (P/B) ratio of 0.19. Some equities with similar Price to Book (P/B) outperform the market in the long run. Amedica recorded a loss per share of 5.25. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 10th of November 2017. Amedica Corporation, a biomaterial company, develops, manufactures, and commercializes a range of medical devices based on its silicon nitride technology platform in the United States, Europe, and South America. Amedica Corporation was founded in 1996 and is headquartered in Salt Lake City, Utah. Amedica operates under Medical Devices classification in USA and is traded on Nasdaq Capital Markets. It employs 33 people. For more info on Amedica please contact Sonny Bal at 801-839-3500 or go to http://www.amedica.com.

Amedica Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Amedica's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Amedica or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Amedica is not yet fully synchronised with the market data
Amedica has some characteristics of a very speculative penny stock
Amedica has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 9.72 M. Net Loss for the year was (20.16 M) with profit before overhead, payroll, taxes, and interest of 9.43 M.
Amedica currently holds about 8.84 M in cash with (7.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.74.

Amedica Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.44 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Amedica's market, we take the total number of its shares issued and multiply it by Amedica's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Amedica Profitablity

Amedica's profitability indicators refer to fundamental financial ratios that showcase Amedica's ability to generate income relative to its revenue or operating costs. If, let's say, Amedica is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Amedica's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Amedica's profitability requires more research than a typical breakdown of Amedica's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (131.93) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (77.73) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $77.73.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Amedica to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Competition Analyzer Now

   

Competition Analyzer

Analyze and compare many basic indicators for a group of related or unrelated entities
All  Next Launch Module
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
Note that the Amedica information on this page should be used as a complementary analysis to other Amedica's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Amedica Stock

If you are still planning to invest in Amedica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amedica's history and understand the potential risks before investing.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Stocks Directory
Find actively traded stocks across global markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals